VANCOUVER, BC, Aug. 14, 2025 /CNW/ – Light AI Inc. (“Light AI” or the “Company“) (CBOE: CA) (CBOE: ALGO) (FSE: 0HC) (OTCQB:OHCFF), a healthcare technology company focused on developing artificial intelligence (“AI”) health diagnostic and wellness solutions, today announced its financial and operating results for its second quarter of 2025 representing the three and six months ended June 30, 2025.   Financial information is reported in Canadian dollars (“$”) unless otherwise stated and in accordance with International Financial Reporting Standards (“IFRS”).

Financial and Operating Results Summary for the three and six months ended June 30, 2025  

The Company is currently in the development stage of its software technology offering anticipated to be completed with related commercialization commencing in late 2025. During the three months ended June 30, 2025, the Company had total operating expenses, exclusive of interest, depreciation and share based payments, of $4.0 million compared to $4.2 million for the three months ended March 31, 2025 and $2.0 million for the three months ended June 30, 2025. The change is primarily attributable to the Company’s incremental investment in its product development with total research and development expenses of $1.4 million in Q2 2025 compared to $1.2 million for the three months ended March 31, 2025 and $1.1 million in the prior year period in addition to marketing and investor relations activities of approximately $2.1 million in Q2 2025 compared to $2.4 million for the three months ended March 31, 2025 and $0.3 million in the prior year period. The Company had total operating expenses of $8.3 million for the six months ended June 30, 2025 which increased from $3.8 million in the prior year period due primarily to marketing and investor relations expenses in addition to increased product development costs.

The Company had cash of $9.4 million with total assets of $10.8 million as at June 30, 2025 compared to cash of $15.2 million with total assets of $17.1 million as at December 31, 2024.  On January 8, 2025, the Company closed the second of …

Full story available on Benzinga.com